ARTICLE | Company News
Genome Therapeutics, Wyeth deal
January 6, 2003 8:00 AM UTC
The companies extended through December 2003 their 1999 research agreement to develop therapeutics for osteoporosis based on the LRP5 gene. GENE said that to date it has received $9 million of the $1...